DiFusion Technologies

Today, as the adaptability of immune cells and the role that biomaterials play on immune-mediated tissue responses becomes better understood, there is a shift towards designing materials that can proactively modulate the immune system. Located in Austin Texas, DiFusion was founded in 2009 and has been dedicated to engineering and bringing to market a suite of patented immunomodulatory, tissue regenerating and antimicrobial polymers. DiFusion has assembled a team of leading clinical and research experts on their scientific advisory board:. Whang is actively involved in clinical and basic science research with a focus on the biology of spinal fusion and bone healing, bone grafting substitutes, and evidence-based medicine. Harborview is a referral center for 4 states and a quarter of the square mileage of the United States, where Dr. Cheng is a member of the American Society of Mechanical Engineers, the Lumbar Spine Research Society, the Orthopedic Research Society and the Spine Arthroplasty Society, among other professional societies. Stephen Badylak is a Professor in the Department of Surgery, and Deputy Director of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. ZFUZE is the first and only man-made material that consistently demonstrated the ability to shift the M1 to M2 phenotype in a rapid and predictable manner at Day 4-5.